CLC Number:
- R473.5
| [1] Rangaswami J,Bhalla V,Blair JEA,et al.Cardiorenal Syndrome:Classification,Pathophysiology,Diagnosis,and Treatment Strategies:A Scientific Statement from the American Heart Association[J].Circulation,2019,139(16):e840-e878.DOI:10.1161/CIR.0000000000000664. [2] McMurray JJ,Adamopoulos S,Anker SD,et al.ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012:The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.Developed in Collaboration with the Heart Failure Association (HFA)of the ESC[J].Eur Heart J,2012,33(14):1787-1847.DOI:10.1093/eurheartj/ehs104. [3] 薛艳梅,唐雯.腹膜透析治疗心肾综合征的研究进展[J].中国血液净化,2019,18(5):322-324.DOI:10.3969/j.issn.1671-4091.2019.05.009. [4] Kazory A.Fluid Overload as A Major Target in Management of Cardiorenal Syndrome:Implications for the Practice of Peritoneal Dialysis[J].World J Nephrol,2017,6(4):168-175.DOI:10.5527/wjn.v6.i4.168. [5] Clementi A,VirzìGM,Goh CY,et al.Cardiorenal Syndrome Type 4:A Review[J].Cardiorenal Med,2013,3(1):63-70.DOI:10.1159/000350397. [6] Suresh H,Arun BS,Venkatesh M,et al.Cardiorenal Syndrome Type 4:A Study of Cardiovascular Diseases in Chronic Kidney Disease[J].Indian Heart J,2017,69(1):11-16.DOI:10.1016/j.ihj.2016.07.006. [7] Unal A,Kavuncuoglu F,Duran M,et al.Inflammation Is Associated to Volume Status in Peritoneal Dialysis Patients[J].Ren Fail,2015,37(6):935-940.DOI:10.3109/0886022X.2015.1040337. [8] Ng JK,Kwan BC,Chow KM,et al.Asymptomatic Fluid Overload Predicts Survival and Cardiovascular Event in Incident Chinese Peritoneal Dialysis Patients[J].PLoS One,2018,13(8):e0202203.DOI:10.1371/journal.pone.0202203. [9] Palmer BF,Clegg DJ.Fluid Overload as A Therapeutic Target for the Preservative Management of Chronic Kidney Disease[J].Curr Opin Nephrol Hypertens,2020,29(1):22-28.DOI:10.1097/mnh.0000000000000563. [10] 许义.容量管理对持续非卧床腹膜透析患者容量负荷及心功能的影响[D].苏州:苏州大学,2014.DOI:10.7666/d.D506538. [11] 朱政,胡雁,邢唯杰,等.不同类型循证问题的构成[J].护士进修杂志,2017,32(21):1991-1994.DOI:10.16821/j.cnki.hsjx.2017.21.025. [12] 孙文茜,赵晨,高维洁,等.循证护理实践中的证据检索方法及资源[J].中国循证心血管医学杂志,2016,8(3):263-266.DOI:10.3969/j.issn.1674-4055.2016.03.03. [13] 周芬,郝玉芳,丛雪,等.指南研究与评价工具AGREE Ⅱ及各领域分值的补充解释及思考[J].护理学报,2018,25(18):56-58.DOI:10.16460/j.issn1008-9969.2018.18.056. [14] 张方圆,沈傲梅,强万敏.AMSTAR使用过程中存在的问题及建议[J].中国循证心血管医学杂志,2018,10(2):138-142.DOI:10.3969/j.issn.1674-4055.2018.02.03. [15] 周英凤,顾莺,胡雁,等.JBI循证卫生保健中心关于不同类型研究的质量评价工具—干预性研究的质量评价[J].护士进修杂志,2018,33(2):112-113.DOI:10.16821/j.cnki.hsjx.2018.02.006. [16] 陈红丽,张戈,赵青,等.近10年国内护理专家共识文献质量评价与分析[J].中国护理管理,2020,20(3):399-406.DOI:10.3969/j.issn.1672-1756.2020.03.017. [17] 赵梦遐,王惠连,朱利敏.我国护理期刊有关随机对照试验系统评价的论文书写质量评价[J].护理学报,2011,18(17):8-12.DOI:10.16460/j.issn1008-9969.2011.17.001. [18] 邢唯杰,胡雁,周英凤,等.推动证据向临床转化(六)证据总结的制作与撰写[J].护士进修杂志,2020,35(12):1129-1132.DOI:10.16821/j.cnki.hsjx.2020.12.016. [19] International Society for Peritoneal Dialysis.ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - assessment and Management of Various Cardiovascular Risk Factors[EB/OL].(2015-01-31)[2020-08-10].https://journals.sagepub.com/doi/pdf/10.3747/pdi.2014.00279.DOI:10.3747/pdi.2014.00279. [20] National Institute for Health and Care Excellence.Multiple Frequency Bioimpedance Devices to Guide Fluid Management in People with Chronic Kidney Disease Having Dialysis[EB/OL].(2017-06-21)[2020-04-01].https://www.nice.org.uk/guidance/dg29. [21] The Renal Association.Renal Association Clinical Practice Guideline on Peritoneal Dialysis in Adults and Children[EB/OL].(2017-06-01)[2020-08-10].https://renal.org/wp-content/uploads/2017/06/final-peritoneal-dialysis-guideline667ba231181561659443ff000014d4d8.pdf.DOI:10.1186/s12882-017-0687-2. [22] Blake PG,Bargman JM,Brimble KS,et al.Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011[J].Perit Dial Int,2011,31(2):218-239.DOI:10.3747/pdi.2011.00026. [23] Gilmore J.KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations-2006 Updates[J].Nephrol Nurs J,2006,33(5):487-488.DOI:10.1093/ndt/gfl229. [24] Covic A,Ciumanghel AI,Siriopol D,et al.Value of Bioimpedance Analysis Estimated"Dry Weight"in Maintenance Dialysis Patients:A Systematic Review and Meta-analysis[J].Int Urol Nephrol,2017,49(12):2231-2245.DOI:10.1007/s11255-017-1698-4. [25] Konings CJ,Kooman JP,Schonck M,et al.Effect of Icodextrin on Volume Status,Blood Pressure and Echocardiographic Parameters:A Randomized Study[J].Kidney Int,2003,63(4):1556-1563.DOI:10.1046/j.1523-1755.2003.00887.x. [26] Hong YA,Yoon HE,Choi BS,et al.The Effect of Strict Volume Control Assessed by Repeated Bioimpedance Spectroscopy on Cardiac Function in Peritoneal Dialysis Patients[J].Sci Rep,2019,9(1):17679.DOI:10.1038/s41598-019-53792-0. [27] 李涌泉,张欣洲,黄旋珠,等.容量控制对腹膜透析患者微炎症及左室肥厚的影响[J].医学临床研究,2007,24(7):1071-1073.DOI:10.3969/j.issn.1671-7171.2007.07.006. [28] Magden K,Hur E,Yildiz G,et al.The Effects of Strict Salt Control on Blood Pressure and Cardiac Condition in End-stage Renal Disease:Prospective-study[J].Ren Fail,2013,35(10):1344-7.DOI:10.3109/0886022X.2013.828259. [29] A?ci G,Ozkahya M,Duman S,et al.Volume Control Associated with Better Cardiac Function in Long-term Peritoneal Dialysis Patients[J].Perit Dial Int,2006,26(1):85-88.DOI:10.1159/000093628. [30] Pinheiro da Silva AL,Vaz da Silva MJ.Type 4 Cardiorenal Syndrome[J].Rev Port Cardiol,2016,35(11):601-616.DOI:10.1016/j.repc.2016.06.007. [31] Wang AY,Dong J,Xu X,et al.Volume Management as A Key Dimension of A High-quality PD Prescription[J].Perit Dial Int,2020,40(3):282-292.DOI:10.1177/0896860819895365. [32] 刘玲玲,黄燕林,杨玉颖,等.基于行为阶段转变理论对腹膜透析患者实施容量管理的效果[J].护理学杂志,2019,34(13):48-51.DOI:10.3870/j.issn.1001-4152.2019.13.048. [33] Kim YL,Biesen WV.Fluid Overload in Peritoneal Dialysis Patients[J].Semin Nephrol,2017,37(1):43-53.DOI:10.1016/j.semnephrol.2016.10.006. [34] 程慧栋,余乐,周岩,等.腹膜透析患者心胸比观察的临床意义[J].肾脏病与透析肾移植杂志,2017,26(3):217-222.DOI:10.3969/cndt.j.issn.1006-298X.2017.03.004. [35] 李偲,杜晓刚.心肾综合征研究进展[J].中华临床医师杂志(电子版),2015,9(5):833-837. [36] Xue Y,Xu B,Su C,et al.Cardiorenal Syndrome in Incident Peritoneal Dialysis Patients:What Is Its Effect on Patients'Outcomes?[J].PLoS One,2019,14(6):e0218082.DOI:10.1371/journal.pone.0218082. [37] Nerenberg KA,Zarnke KB,Leung AA,et al.Hypertension Canada's 2018 Guidelines for Diagnosis,Risk Assessment,Prevention,and Treatment of Hypertension in Adults and Children[J].Can J Cardiol,2018,34(5):506-525.DOI:10.1016/j.cjca.2018.02.022. [38] 肖希,余学清,阳晓.腹膜透析小分子溶质清除评估研究进展[J].中国血液净化,2019,18(4):217-219.DOI:10.3969/j.issn.1671-4091.2019.03.001. [39] Kernick D,Chew-Graham CA,O'Flynn N.Clinical Assessment and Management of Multimorbidity:NICE Guideline[J].Br J Gen Pract,2017,67(658):235-236.DOI:10.3399/bjgp17X690857. [40] 杨玉颖,黄燕林,刘玲玲,等.信息-动机-行为技巧模型延伸服务对居家腹膜透析患者饮食行为的影响[J].护理学报,2019,26(20):1-4.DOI:10.16460/j.issn1008-9969.2019.20.001. [41] Zuo ML,Yue WS,Yip T,et al.Prevalence of and Associations with Reduced Exercise Capacity in Peritoneal Dialysis Patients[J].Am J Kidney Dis,2013,62(5):939-946.DOI:10.1053/j.ajkd.2013.05.016. [42] 杜理平,单岩,常天颖,等.腹膜透析病人体力活动研究进展[J].护理研究,2019,33(14):2422-2426.DOI:10.12102/j.issn.1009-6493.2019.14.011. [43] 颜彬,李双庆.艾考糊精透析液的研究进展及展望[J].兰州大学学报(医学版),2017,43(3):62-68.DOI:10.13885/j.issn.1000-2812.2017.03.013. [44] Wang Z,Wen Y,Liang J,et al.The Influence of Low Calcium Dialysate on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients[J].Ren Fail,2016,38(10):1665-1671.DOI:10.1080/0886022X.2016.1229986. |
|